Type 1 Diabetes (T1D) is a chronic autoimmune disease characterized by the destruction of pancreatic beta cells, leading to lifelong insulin dependency. While insulin therapy is central to T1D management, a holistic approach that considers the broader endocrine and metabolic aspects of the disease is increasingly essential. Integrative approaches, including stress management, emotional regulation, and personalized nutrition, are particularly important for patients struggling with self-management or experiencing complex endocrine-related complications.
T1D is often accompanied by a higher burden of comorbid conditions, such as depression, eating disorders, and metabolic syndrome, including the emergence of Type 2 Diabetes (T2D). These conditions can be linked to the broader endocrine dysfunctions that occur in T1D, such as disruptions of the hypothalamic-pituitary-adrenal axis and altered responses to stress hormones like cortisol. While advancements in diabetes technology, such as insulin pumps and Automated Insulin Delivery (AID) systems, have significantly improved glycemic control, they do not fully address the endocrine and psychological challenges that many patients face. Integrative medicine approaches, which emphasize the balance of the entire system, could play a key role in preventing further complications and improving overall outcomes for patients with T1D.
There is growing recognition that patients with T1D can benefit from integrative approaches, enhancing their ability to manage their health more holistically and fostering greater self-efficacy and empowerment. Evidence from practices such as Ayurvedic medicine or fasting suggests that even patients with T1D can achieve significant improvements in endocrine function and overall health through these strategies.
The topic aims to cover gaps or explore in more detail these fields but is not limited to:
• Exploring how chronic stress and dysregulation of stress hormones like cortisol affect endocrine function in T1D and how integrative approaches can mitigate these effects.
• Assessing the impact of diet, including fasting and specific nutritional strategies, on endocrine function and metabolic outcomes in patients with T1D.
• Examining the potential for combining advanced diabetes management technologies with approaches that also address broader endocrine health, creating a more comprehensive care model.
• Investigating how integrative approaches can help manage the endocrine-related comorbidities in patients with T1D, including the prevention of T2D and metabolic syndrome.
• Understanding how integrative approaches can support patient autonomy in managing not only blood glucose but also their overall health.
Keywords:
Type 1 Diabetes (T1D), Autoimmune disease, Insulin dependency, Endocrine function, Metabolic syndrome, Integrative approaches, Chronic stress, Cortisol, Comorbid conditions, Advanced diabetes management technologies.
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Type 1 Diabetes (T1D) is a chronic autoimmune disease characterized by the destruction of pancreatic beta cells, leading to lifelong insulin dependency. While insulin therapy is central to T1D management, a holistic approach that considers the broader endocrine and metabolic aspects of the disease is increasingly essential. Integrative approaches, including stress management, emotional regulation, and personalized nutrition, are particularly important for patients struggling with self-management or experiencing complex endocrine-related complications.
T1D is often accompanied by a higher burden of comorbid conditions, such as depression, eating disorders, and metabolic syndrome, including the emergence of Type 2 Diabetes (T2D). These conditions can be linked to the broader endocrine dysfunctions that occur in T1D, such as disruptions of the hypothalamic-pituitary-adrenal axis and altered responses to stress hormones like cortisol. While advancements in diabetes technology, such as insulin pumps and Automated Insulin Delivery (AID) systems, have significantly improved glycemic control, they do not fully address the endocrine and psychological challenges that many patients face. Integrative medicine approaches, which emphasize the balance of the entire system, could play a key role in preventing further complications and improving overall outcomes for patients with T1D.
There is growing recognition that patients with T1D can benefit from integrative approaches, enhancing their ability to manage their health more holistically and fostering greater self-efficacy and empowerment. Evidence from practices such as Ayurvedic medicine or fasting suggests that even patients with T1D can achieve significant improvements in endocrine function and overall health through these strategies.
The topic aims to cover gaps or explore in more detail these fields but is not limited to:
• Exploring how chronic stress and dysregulation of stress hormones like cortisol affect endocrine function in T1D and how integrative approaches can mitigate these effects.
• Assessing the impact of diet, including fasting and specific nutritional strategies, on endocrine function and metabolic outcomes in patients with T1D.
• Examining the potential for combining advanced diabetes management technologies with approaches that also address broader endocrine health, creating a more comprehensive care model.
• Investigating how integrative approaches can help manage the endocrine-related comorbidities in patients with T1D, including the prevention of T2D and metabolic syndrome.
• Understanding how integrative approaches can support patient autonomy in managing not only blood glucose but also their overall health.
Keywords:
Type 1 Diabetes (T1D), Autoimmune disease, Insulin dependency, Endocrine function, Metabolic syndrome, Integrative approaches, Chronic stress, Cortisol, Comorbid conditions, Advanced diabetes management technologies.
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.